Clinical trials: Retinal Disease, Electroretinogram
- Condition Retinal Disease, Electroretinogram
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Retinal Disease, Electroretinogram
RETeval All Comers Trial (REACT)
The primary objective of this study is to collect electroretinogram ERG measurements from visually normal and abnormal subjects using the FDA cleared RETeval device (K142567).
- Trial name
- REACT (NCT03065881)
- Testing
- RETeval
- Where
- United States
- Volunteers
- 664 people, healthy volunteers welcome
- Sponsor
- LKC Technologies, Inc.